National Partnership for Women & Families

Research Library: Health Care

Doing some policy research? Need some background materials? You've come to the right place.

Note: Documents in the library are organized by issue area — and PDFs require Adobe Reader (free download/upgrade available).

 

 

Letter to FDA Commissioner Von Eschenbach urging not to cut Women's Health

We are extremely troubled by reports that the FDA is attempting to cut the Office of Women’s Health (OWH) 2007 budget by approximately $1.2 million nearly one third of its $4 million budget approved by the President and Congress. The OWH has spent or budgeted the remaining $2.8 million for staff salaries and projects already in progress, so this cut would effectively shut down the office’s operations for the rest of the fiscal year.


Family Planning Coalition Letter opposing Keroack appointment

The undersigned organizations are writing to express our grave concern over the appointment of Dr. Eric Keroack as the new Deputy Assistant Secretary for Population Affairs (DASPA). As you know, the DASPA oversees Title X, the nation’s family planning program, which provides high-quality family planning and preventive health care services to over five million low-income individuals annually, helping them to avoid approximately one million unintended pregnancies each year.


Amicus Brief: Gonzales v. Carhart; Gonzales v. Planned Parenthood

The evidence presented by a host of respected physicians in the cases challenging the Act demonstrates that women may be virtually unable to obtain any safe abortion at all during and after the fourth month of pregnancy because of the Act’s broad reach, and, even if narrowly construed, the Act can deny women access to the safest available procedure.


GAO: Decision Process to Deny Over-the-Counter Status for Emergency Contraception Plan B Unusual

We write in response to the Advance Notice of Proposed Rulemaking in docket number 2005N-0345 regarding Barr Laboratories’ application for over-the-counter (OTC) status for Plan B® emergency contraception (EC). Given the overwhelming recommendation of the FDA’s independent expert advisory committees and professional staff that Plan B® is safe and effective for women of all ages and should be made available OTC, we strongly urge you to stop the unnecessary rulemaking process and make the product available without restrictions for women of all ages without further delay.


Comments to FDA on Over-the-Counter Status for Plan B

We write in response to the Advance Notice of Proposed Rulemaking in docket number 2005N-0345 regarding Barr Laboratories’ application for over-the-counter (OTC) status for Plan B® emergency contraception (EC). Given the overwhelming recommendation of the FDA’s independent expert advisory committees and professional staff that Plan B® is safe and effective for women of all ages and should be made available OTC, we strongly urge you to stop the unnecessary rulemaking process and make the product available without restrictions for women of all ages without further delay.


Letter on AHPs and Women's Health

Instead of providing broader access to comprehensive health insurance for the millions of uninsured American women and families, H.R. 525 will undermine women’s access to quality, affordable health insurance and may actually increase the ranks of the uninsured.


Letter to Representative Mike Castle on Stem Cell Research Enhancement

I am writing to express strong support for passage of H.R. 810, the Stem Cell Research Enhancement Act of 2005, which would expand the ability of researchers to pursue federally funded stem cell research. H.R. 810 would promote medical research that is critical to women both as patients and caregivers.


Letter to Senate HELP Committee Opposing AHPs

On behalf of the National Partnership for Women & Families, I urge you to oppose S. 406, the federal association health plan (AHP) legislation, that will be discussed during this week’s hearing on health care solutions for small businesses. This legislation is bad medicine for our nation’s health care system, especially for women small business owners and their workers.


Testimony Supporting Maryland Pharmacy Access Legislation

Access to safe and effective contraception is essential to women’s reproductive health. Consistent with that goal, the National Partnership submits this testimony in support of SB 541, a bill that would allow Maryland women to obtain emergency contraception – also known as the “morning after pill – directly from a trained, licensed pharmacist pursuant to a written protocol developed with a physician.


Protect Your Healthcare Letter Opposing H.R. 525

Rising health care costs and the increasing numbers of Americans without health insurance is a major national problem that requires action and attention. However, AHPs are not a solution to the access and affordability problems facing small firms and would, in fact, make the current problem even worse, resulting in higher premiums and less secure coverage for the vast majority of small businesses.


Letter to Speaker Hastert Opposing H.R. 660

On behalf of the National Partnership for Women & Families to urge you to oppose the Association Health Plan (AHP) legislation scheduled for a vote in the House next week. Although this proposal is being offered to help the uninsured, it fails to deliver on its promise and could actually make the problem worse, especially for women small business owners and their workers.


We Stand On Moral Ground: Ad released on the anniversary of the March for Women's Lives

We stand for healthy women and families. We stand for access to basic health care, including birth control, emergency contraception, sex education, STD testing and treatment, prenatal care, and abortion. we stand for medical privacy. We stand for women’s lives. We stand on moral ground.


Statement of Debra L. Ness at the March for Womens Lives

Wow! What a thrill it is to look out on this sea of pro-choice faces, to know that hundreds of thousands of people have come from all over the country – all over the world – to stand up for women’s lives. It’s been a long time since America’s pro-choice majority has dominated thescene. Too long. But we’re here today to change that. With this march, we begin a new era.


National Partnership Letter to Preserve Teen Access to Contraception; Oppose Vitter Ammendments to FY08 Labor HHS Appropriations

The National Partnership for Women & Families strongly urges you to oppose any amendments to the FY 2008 Labor, Health and Human Services, and Education appropriations bill filed by Senator David Vitter (R-LA) intended to render health clinics that provide abortion care with non-federal dollars, under almost all circumstances, ineligible for funding through the bill.


Letter to FDA Commissioner Mark McClellan on Plan B

Before you move on to your next challenge, we request that you make one more decision that upholds the credibility and integrity of the Food and Drug Administration, which you have so ably led. We believe it is important, in your current capacity as FDA Administrator, to make a decision on the Plan B over-the-counter (OTC) application based solely on the scientific evidence and the benefits for women’s health and wellbeing.


Letter Opposing S.2061

We are writing to urge you to oppose any effort to bring S. 2061, the misnamed “Healthy Mothers and Healthy Babies Access to Care Act,” to the Senate floor. By singling out pregnant women and their babies, S. 2061 is the most troubling attempt yet to place limits on the legal rights of individuals who have been harmed by someone else’s negligence or wrongdoing.


Comments on President's Council on Bioethics

The National Partnership for Women & Families strongly supports allowing research using Somatic Cell Nuclear Transfer (SCNT), commonly known as therapeutic cloning. The purpose of this technology is to develop treatments for diseases and give millions of people access to life-saving therapies using their own DNA.


Comments submitted by the Coalition

The undersigned organizations are writing to strongly object to the “Provider Conscience” regulation proposed on August 26, 2008 by the Department of Health and Human Services (HHS). The proposed regulation is unnecessary, threatens to significantly undermine patients’ access to critical health care services and information, and could negatively impact scientific research.


AHP Testimony (March 2003)

The testimony of Alice M. Weiss, the Director of Health Policy at the National Partnership for Women & Families, before the U.S. House Committee on Education and the Workforce Subcommittee on Employer-Employee Relations on “H.R. 660, The Small Business Health Fairness Act.”


AHP Testimony (February 2003)

The testimony of Judith L. Lichtman, President of the National Partnership for Women & Families, before the U.S. Senate Small Business & Entrepreneurship Committee on “The Small Business Health Care Crisis: Possible Solutions.”


Items 181 - 200 of 276  Previous12345678910Next
  Please leave this field empty